Cumberland Pharmaceuticals Inc. (CPIX)

CPIX Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	17.96	18.32	19.76	27.04	24.75
Cash & Short-Term Investments	17.96	18.32	19.76	27.04	24.75
Cash Growth	-1.95%	-7.27%	-26.93%	9.24%	-12.26%
Receivables	11.7	9.76	13.16	6.88	12.38
Inventory	4	4.61	9.86	8.43	10.64
Prepaid Expenses	2.79	3.03	3.08	3.34	2.2
Total Current Assets	36.45	35.71	45.87	45.69	49.97
Property, Plant & Equipment	6.45	7.04	5.5	1.47	2.6
Goodwill	0.91	0.91	0.91	0.88	0.88
Other Intangible Assets	17.97	22.61	30.59	23.95	28.12
Other Long-Term Assets	13.79	15.5	10.05	12.47	14.89
Total Assets	75.58	81.78	92.93	84.46	96.46
Accounts Payable	13.91	14.04	10.82	9.64	13.4
Accrued Expenses	9.74	9.16	10.8	5.04	5.36
Short-Term Debt	5.1	-	-	-	-
Current Portion of Leases	0.36	0.35	0.17	0.97	1.02
Other Current Liabilities	2.51	4.43	6.79	3.63	5.89
Total Current Liabilities	31.62	27.98	28.58	19.28	25.67
Long-Term Debt	10.18	12.78	16.2	15	15
Long-Term Leases	4.94	5.3	4.59	0.09	1.06
Other Long-Term Liabilities	6.3	6.45	7.59	7.49	7.86
Total Liabilities	53.04	52.52	56.95	41.86	49.59
Common Stock	46.82	47.09	47.47	48.45	49.12
Retained Earnings	-23.97	-17.49	-11.21	-5.64	-2.13
Total Common Equity	22.85	29.6	36.27	42.81	46.99
Minority Interest	-0.31	-0.34	-0.29	-0.21	-0.12
Shareholders' Equity	22.55	29.26	35.97	42.6	46.87
Total Liabilities & Equity	75.58	81.78	92.93	84.46	96.46
Total Debt	20.57	18.43	20.96	16.06	17.08
Net Cash (Debt)	-2.61	-0.11	-1.2	10.98	7.68
Net Cash Growth	-	-	-	43.03%	14.32%
Net Cash Per Share	-0.19	-0.01	-0.08	0.74	0.51
Filing Date Shares Outstanding	13.97	14.18	14.4	14.84	14.92
Total Common Shares Outstanding	13.95	14.12	14.37	14.74	14.99
Working Capital	4.83	7.73	17.29	26.41	24.3
Book Value Per Share	1.64	2.10	2.52	2.90	3.14
Tangible Book Value	3.97	6.08	4.76	17.98	17.99
Tangible Book Value Per Share	0.28	0.43	0.33	1.22	1.20
Machinery	1.84	1.81	1.58	2.81	2.72
Leasehold Improvements	0.83	0.8	0.79	1.42	1.41

Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q